A simple and sensitive method to analyze genotoxic impurity hydrazine in pharmaceutical materials

Area of Science:

• Analytical Chemistry
• Pharmaceutical Analysis
• Impurity Profiling

Background:

• Hydrazine (N2H4) is a genotoxic impurity requiring strict control in pharmaceuticals.
• Conventional analytical methods struggle with hydrazine's properties (no chromophore, high polarity, volatility) and matrix interference.

Purpose of the Study:

• To develop a simple, accurate, and sensitive method for trace hydrazine determination in pharmaceutical materials.
• To overcome challenges in hydrazine analysis, including low sensitivity and matrix interference.

Main Methods:

• Reversed-phase liquid chromatography coupled with UV derivatization.
• Using 2-Hydroxy-1-Naphthalaldehyde (HNA) as a derivatizing reagent to form a hydrazone product.
• Employing derivatization to attach chromophores, shift lambda max, and improve chromatographic resolution.

Main Results:

• The derivatization product (hydrazone) exhibits strong UV absorbance at 406/424nm, well-shifted from typical pharmaceutical matrix interferences (190-380nm).
• Achieved a low detection limit of 0.25ppm (0.25μg/g API).
• Demonstrated method validation and application for pharmaceutical process control and drug material release.

Conclusions:

• The developed method effectively addresses hydrazine's analytical challenges, offering high sensitivity and selectivity.
• This UV derivatization technique provides a robust solution for quantifying trace genotoxic impurities like hydrazine.
• The method is suitable for routine pharmaceutical quality control and release testing.